Prdx1 Reduces Intracerebral Hemorrhage-Induced Brain Injury via Targeting Inflammation- and Apoptosis-Related mRNA Stability

Guoqiang Yang, Jiacheng Huang, Junjie Yuan, Qin Zhang, Chang‐Xiong Gong, Qiong Chen, Qi Xie, Lexing Xie, Ru Chen, Zhongming Qiu, Kai Zhou, Rui‐Hua Xu, Guohui Jiang, Xiao‐Yi Xiong, Qingwu YangFrontiers in Neuroscience 2020 · DOI

Abstract

RNA-binding proteins (RBPs) have been shown to be involved in posttranscriptional regulation, which plays an important role in the pathophysiology of intracerebral hemorrhage (ICH). Peroxiredoxin 1 (Prdx1), an RBP, plays an important role in regulating inflammation and apoptosis. On the basis that inflammation and apoptosis may contribute to ICH-induced brain injury, in this study, we used ICH models coupled with in vitro experiments, to investigate the role and mechanism of Prdx1 in regulating inflammation and apoptosis by acting as an RBP after ICH. We first found that Prdx1 was significantly up-regulated in response to ICH-induced brain injury and was mainly expressed in astrocytes and microglia in ICH rat brains. After overexpressing Prdx1 by injecting adeno-associated virus (AAV) into the striatum of rats at 3 weeks, we constructed ICH models and found that Prdx1 overexpression markedly reduced inflammation and apoptosis after ICH. Furthermore, RNA immunoprecipitation combined with high-throughput sequencing (RIP-seq) in vitro revealed that Prdx1 affects the stability of inflammation- and apoptosis-related mRNA, resulting in the inhibition of inflammation and apoptosis. Finally, overexpression of Prdx1 significantly alleviated the symptoms and mortality of rats subjected to ICH. Our results show that Prdx1 reduces ICH-induced brain injury by targeting inflammation- and apoptosis-related mRNA stability. Prdx1 may be an improved therapeutic target for alleviating the brain injury caused by ICH.

Introduction

Intracerebral hemorrhage (ICH)—bleeding within the brain tissue—is a devastating form of stroke characterized by high mortality and limited clinical treatment options. While the primary injury is caused by the physical impact of the hematoma, the subsequent "secondary injury" driven by runaway neuroinflammation and programmed cell death (apoptosis) often leads to the most lasting neurological damage.

Researchers are increasingly looking at post-transcriptional regulation—how cells control the lifespan and activity of mRNA—as a key factor in this pathophysiology. This study focuses on Peroxiredoxin 1 (Prdx1), an RNA-binding protein (RBP) that acts as a "molecular stabilizer" for genetic blueprints that suppress inflammation and cell death.

Methodology

The study utilized a combination of in vivo rat models and in vitro molecular biology techniques. Researchers induced ICH in Sprague-Dawley rats by injecting autologous blood into the striatum. To test the therapeutic potential of Prdx1, they used an adeno-associated virus (AAV) to overexpress the protein in the rat brain three weeks prior to inducing the hemorrhage.

Experimental workflow for the study, detailing the animal groups and molecular assays used in vivo and in vitro.

Key analytical techniques included:

  • RIP-seq (RNA Immunoprecipitation Sequencing): To identify the specific mRNA molecules that Prdx1 binds to.
  • RNA-seq: To map global gene expression changes when Prdx1 is overexpressed.
  • Standard Assays: Western blotting, qRT-PCR, and immunofluorescence were used to track protein levels and cellular localization.

Results and Discussion

Prdx1 as a Glial-Specific Defense

Following a brain bleed, Prdx1 levels naturally spike, peaking at approximately 72 hours post-injury. Interestingly, this upregulation is cell-specific, occurring primarily within astrocytes and microglia—the brain's support and immune cells—rather than neurons. This suggests a targeted glial response to mitigate injury.

Prdx1 expression patterns, survival benefits, and cellular localization following ICH.

Impact on Survival and Recovery

Overexpressing Prdx1 provided significant neuroprotection in the rat models. Key findings included:

  • Reduced Mortality: Prdx1 overexpression significantly lowered mortality rates and improved neurological scores (mNSS).
  • Decreased Brain Swelling: Brain water content (BWC), a measure of dangerous edema, was significantly lower in the treated group.
  • Tissue Preservation: Histological staining confirmed more surviving neurons and fewer damaged cells in the area surrounding the bleed.

Mechanistic Insights: Stabilizing the "Good" Messages

Using RIP-seq, the team identified over 10,000 genes that Prdx1 binds to. The protein acts by stabilizing mRNAs for anti-inflammatory and anti-apoptotic factors like ANGPTL4, GADD45A, and THBS1. By keeping these protective "blueprints" around longer, the cell can produce more proteins that dampen the inflammatory cascade and prevent self-destruction.

Limitations and Future Outlook

While the results are promising, moving from AAV-based gene therapy in rats to human clinical treatment is a significant hurdle. The authors noted that Prdx1-knockdown rats often died within three days of ICH, highlighting the protein's essential role in survival but making loss-of-function studies difficult. Future work will need to map the exact biochemical mechanism of how Prdx1 prevents mRNA degradation and explore viable delivery methods for acute human stroke cases.

Data Availability

The high-throughput sequencing datasets (RIP-seq and RNA-seq) are deposited in the Gene Expression Omnibus (GEO) under accession number GSE134505.

Summary updated

Abstract

RNA-binding proteins (RBPs) have been shown to be involved in posttranscriptional regulation, which plays an important role in the pathophysiology of intracerebral hemorrhage (ICH). Peroxiredoxin 1 (Prdx1), an RBP, plays an important role in regulating inflammation and apoptosis. On the basis that inflammation and apoptosis may contribute to ICH-induced brain injury, in this study, we used ICH models coupled with <i>in vitro</i> experiments, to investigate the role and mechanism of Prdx1 in regulating inflammation and apoptosis by acting as an RBP after ICH. We first found that Prdx1 was significantly up-regulated in response to ICH-induced brain injury and was mainly expressed in astrocytes and microglia in ICH rat brains. After overexpressing Prdx1 by injecting adeno-associated virus (AAV) into the striatum of rats at 3 weeks, we constructed ICH models and found that Prdx1 overexpression markedly reduced inflammation and apoptosis after ICH. Furthermore, RNA immunoprecipitation combined with high-throughput sequencing (RIP-seq) <i>in vitro</i> revealed that Prdx1 affects the stability of inflammation- and apoptosis-related mRNA, resulting in the inhibition of inflammation and apoptosis. Finally, overexpression of Prdx1 significantly alleviated the symptoms and mortality of rats subjected to ICH. Our results show that Prdx1 reduces ICH-induced brain injury by targeting inflammation- and apoptosis-related mRNA stability. Prdx1 may be an improved therapeutic target for alleviating the brain injury caused by ICH.
BibTeX
@inproceedings{yang2020prdx,
  author = {Guoqiang Yang and Jiacheng Huang and Junjie Yuan and Qin Zhang and Chang‐Xiong Gong and Qiong Chen and Qi Xie and Lexing Xie and Ru Chen and Zhongming Qiu and Kai Zhou and Rui‐Hua Xu and Guohui Jiang and Xiao‐Yi Xiong and Qingwu Yang},
  title = {{Prdx1 Reduces Intracerebral Hemorrhage-Induced Brain Injury via Targeting Inflammation- and Apoptosis-Related mRNA Stability}},
  booktitle = {Frontiers in Neuroscience},
  year = {2020},
  doi = {10.3389/fnins.2020.00181},
}
Figure